The Dark Side of Marketing: OxyContin's Role in the Opioid Epidemic

In today's episode of "Selling Cures," we delve into a dark chapter of pharmaceutical marketing that significantly impacted American healthcare: the aggressive promotion of OxyContin in the 1990s and 2000s. Once hailed as a breakthrough in pain management, this powerful opioid painkiller by Purdue Pharma became the epicenter of one of the most devastating public health crises in U.S. history—the opioid epidemic. Join us as we explore how Purdue's unprecedented marketing strategies and misleading claims about the drug's safety led to widespread misuse, addiction, and tragic consequences. This cautionary tale underscores the critical importance of transparency, ethical responsibility, and accountability in pharmaceutical marketing. Stay tuned for an eye-opening journey through the rise and fall of OxyContin.Timestamps:00:00 Purdue aggressively marketed OxyContin as safe, effective.06:41 OxyContin's marketing highlights ethics over profit.07:44 Stay healthy and safe until then.TopHealth - We're a media network focused exclusively on thought leadership in healthcare. Think of us of a network of podcasts, web series, newsletters, and much more!TopHealth LinkedIn - https://www.linkedin.com/company/tophealth-care/“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”